BMO Capital Upgrades Genmab A/S (GMAB) to Outperform ‘On Improved Outlook ex-Darzalex, Pipeline Optionality’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/BMO+Capital+Upgrades+Genmab+AS+%28GMAB%29+to+Outperform+%27On+Improved+Outlook+ex-Darzalex%2C+Pipeline+Optionality%27/22821405.html for the full story.